当前位置： SCI文献检索 > AMERICAN JOURNAL OF NEPHROLOGY期刊下所有文献 > Association between circulating thrombopoietin levels and cardiovascular risk prediction scores in renal transplant recipients.

Association between circulating thrombopoietin levels and cardiovascular risk prediction scores in renal transplant recipients.

Abstract：

BACKGROUND/AIMS:The 7-year Major Adverse Cardiovascular Events Calculator (CRCRTR-MACE) predicts cardiovascular events (CVE) in renal transplant recipients (RTR), and thrombopoietin (TPO) is a humoral inflammatory factor implicated in cardiovascular disease (CVD). The aim of the study was to determine if circulating TPO levels in stable RTR are positively associated with variable(s) in the CRCRTR-MACE score. METHODS:CRCRTR-MACE scores were calculated in 95 stable RTR. TPO levels were measured by multiplexed fluorescent bead-based immunoassay in all patients and 48 controls. Multivariate analysis (MVA) was performed between TPO and CV risk variables and patient demographics. Stepwise regression with backward elimination of insignificant variables estimated the impact of risk variables on TPO levels. Significance was defined at p < 0.05. Normalized data were presented as mean ± SD and non-normalized data as median (maximum to minimum). RESULTS:The risk of a CVE within 7 years as predicted by the median was 9.97% (range 1.93-84.2). The percentage of patients who were above 20% risk for a CVE was 28.4%. Control TPO level of 170.41 (4.4-995.9) pg/ml was significantly lower than that of 237.90 (32.77-1,386.79) pg/ml in RTR (p = 0.010). TPO level correlated significantly with the total CRCRTR-MACE score (R = 0.310, p = 0.004), smoking (p = 0.009) and eGFR (R = -0.275, p = 0.012) but not with age, diabetes, LDL level or history of CVE. Only the total CRCRTR-MACE score (p = 0.013) and smoking (p = 0.009) remained significant in the MVA. Stepwise regression estimated that smoking increased TPO levels by 206.28 pg/ml and each 10% increase in CRCRTR-MACE score increased TPO levels by an additional 44.4 pg/ml. CONCLUSION:TPO levels are increased in RTR with high CRCRTR-MACE, particularly in smokers with diminished eGFR. Circulating TPO may serve as a biomarker and treatment target for CVD in RTR.

journal_name

Am J Nephrol

journal_title

American journal of nephrology

authors

Mansell H,Elmoselhi H,Shoker A

doi

10.1159/000377641

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

147-55

issue

eissn

0250-8095

issn

1421-9670

pii

000377641

journal_volume

pub_type

杂志文章

在线工具

Association between circulating thrombopoietin levels and cardiovascular risk prediction scores in renal transplant recipients.